腹膜透析处方与充分性在临床实践中的应用:核心课程2023
随着全球腹膜透析(PD)患病率持续增长,临床医生需掌握以患者需求和偏好为中心的处方策略。PD是有效的肾脏替代治疗形式,相比中心血透(HD)具有日程更灵活、血流动力学稳定、更好保护残余肾功能等优势,但有时这些优势被过度关注小分子溶质清除目标所掩盖。以患者为中心的方法强调个体化治疗,尤其考虑递增式PD和符合生活方式偏好的处方。
要点
- PD是有效的肾脏替代治疗形式,相比中心HD日程更灵活,并具有血流动力学稳定和更好保护残余肾功能的优势。
- 过度强调小分子溶质清除目标可能掩盖PD的上述优势,应以患者需求和临床目标为中心。
- 以患者为中心的方法强调个体化治疗,包括递增式PD和符合生活方式偏好的处方。
核心结论
- 将重点从小分子溶质清除目标转向患者需求和临床目标,PD仍是具有吸引力、以患者为中心的肾脏替代治疗形式。
研究设计与样本
- 核心课程2023(综述/教育性综述),检索范围原文未报告。
主要发现
- PD相比中心HD具有日程更灵活、清除盐和水而不引起明显血流动力学变化、持续而温和清除溶质和液体与更好保护残余肾功能相关的优势。
临床怎么用
- 临床医生应掌握以患者需求和偏好为中心的处方策略。
- 考虑递增式PD和符合生活方式偏好的其他处方,强调个体化治疗。
- 将重点从小分子溶质清除目标转向患者需求和临床目标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
As the global prevalence of peritoneal dialysis (PD) continues to grow, practitioners must be equipped with prescribing strategies that focus on the needs and preferences of patients. PD is an effective form of kidney replacement therapy that offers numerous benefits to patients, including more flexibility in schedules compared with in-center hemodialysis (HD). Additional benefits of PD include salt and water removal without significant changes in patient hemodynamics. This continuous yet gentle removal of solutes and fluid is associated with better-preserved residual kidney function. Unfortunately, sometimes these advantages are overlooked at the expense of an emphasis on achieving small solute clearance targets. A more patient-centered approach emphasizes the importance of individualized treatment, particularly when considering incremental PD and other prescriptions that align with lifestyle preferences. In shifting the focus from small solute clearance targets to patient needs and clinical goals, PD remains an attractive, patient-centered form of kidney replacement therapy.
引用
- Auguste BL, Bargman JM. Peritoneal Dialysis Prescription and Adequacy in Clinical Practice: Core Curriculum 2023. Am J Kidney Dis. 2022. PMID: 36208963. doi:10.1053/j.ajkd.2022.07.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。